An Efficacy, and Safety Study Of BXCL501 For The Treatment Of Agitation Associated With Dementia
Clinical trial NCT05276830 · TERMINATED
Trial details
- NCT number
- NCT05276830
- Sponsor
- BioXcel Therapeutics Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-08
- Primary completion
- 2022-04-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.